Takuya Tada
New York University(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Animal Virus Infections Studies, SARS-CoV-2 detection and testing, Virus-based gene therapy research
Most-Cited Works
- → Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies(2022)148 cited
- → MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins(2015)145 cited
- → Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies(2021)114 cited
- → Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants(2021)109 cited
- → B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV(2021)99 cited
- → Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy(2022)94 cited
- → Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies(2022)93 cited
- → An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2(2020)87 cited
- → CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis(2015)85 cited
- → Toll-like receptor agonist R848 blocks Zika virus replication by inducing the antiviral protein viperin(2018)77 cited